Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Funds Are Crazy About Cavium Inc (CAVM)

At the moment, there are dozens of metrics investors can use to track publicly traded companies. A couple of the most under-the-radar are hedge fund and insider trading sentiment. At Insider Monkey, our research analyses have shown that, historically, those who follow the best picks of the elite hedge fund managers can outperform the S&P 500 by a superb margin (see just how much).

Just as useful, optimistic insider trading activity is a second way to analyze the world of equities. As the old adage goes: there are a number of incentives for a corporate insider to sell shares of his or her company, but just one, very clear reason why they would buy. Several academic studies have demonstrated the market-beating potential of this method if shareholders know where to look (learn more here).

Cavium Inc (NASDAQ:CAVM)

Now that that’s out of the way, let’s analyze the recent info for Cavium Inc (NASDAQ:CAVM).

What have hedge funds been doing with Cavium Inc (NASDAQ:CAVM)?

At Q2’s end, a total of 18 of the hedge funds we track were long in this stock, a change of 20% from the previous quarter. With hedge funds’ positions undergoing their usual ebb and flow, there exists a few key hedge fund managers who were boosting their holdings significantly.

According to our 13F database, Ryan Frick and Oliver Evans’s Dorsal Capital Management had the biggest position in Cavium Inc (NASDAQ:CAVM), worth close to $27.4 million, comprising 4.3% of its total 13F portfolio. Coming in second is Eric Bannasch of Cadian Capital, with a $12.9 million position; 0.4% of its 13F portfolio is allocated to the company. Remaining peers with similar optimism include Van Schreiber’s Bennett Lawrence Management, Brian Ashford-Russell and Tim Woolley’s Polar Capital and Peter Rathjens, Bruce Clarke and John Campbell’s Arrowstreet Capital.

As aggregate interest spiked, particular hedge funds have jumped into Cavium Inc (NASDAQ:CAVM) headfirst. Dorsal Capital Management, managed by Ryan Frick and Oliver Evans, established the biggest position in Cavium Inc (NASDAQ:CAVM). Dorsal Capital Management had 27.4 million invested in the company at the end of the quarter. Eric Bannasch’s Cadian Capital also initiated a $12.9 million position during the quarter. The following funds were also among the new CAVM investors: Van Schreiber’s Bennett Lawrence Management, Brian Ashford-Russell and Tim Woolley’s Polar Capital, and Peter Rathjens, Bruce Clarke and John Campbell’s Arrowstreet Capital.

Insider trading activity in Cavium Inc (NASDAQ:CAVM)

Legal insider trading, particularly when it’s bullish, is best served when the primary stock in question has experienced transactions within the past 180 days. Over the last 180-day time period, Cavium Inc (NASDAQ:CAVM) has seen zero unique insiders purchasing, and zero insider sales (see the details of insider trades here).

We’ll also examine the relationship between both of these indicators in other stocks similar to Cavium Inc (NASDAQ:CAVM). These stocks are Atmel Corporation (NASDAQ:ATML), Cypress Semiconductor Corporation (NASDAQ:CY), Mellanox Technologies, Ltd. (NASDAQ:MLNX), Advanced Micro Devices, Inc. (NYSE:AMD), and Vishay Intertechnology (NYSE:VSH). This group of stocks belong to the semiconductor – broad line industry and their market caps are similar to CAVM’s market cap.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.